These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11835339)

  • 21. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
    Cuenco GM; Ren R
    Oncogene; 2004 Jan; 23(2):569-79. PubMed ID: 14724585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis.
    Watanabe N; Kobayashi H; Hirama T; Kikuta A; Koizumi S; Tsuru T; Kaneko Y
    Cancer Genet Cytogenet; 2002 Jul; 136(1):10-6. PubMed ID: 12165445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of translocational breakpoints within the intron region before the last coding exon (exon 12) of the EVI1 gene in two cases of CML-BC with inv(3)(q21q26).
    Suzukawa K; Taki T; Abe T; Asoh H; Kamada N; Yokota J; Morishita K
    Genomics; 1997 Jun; 42(2):356-60. PubMed ID: 9192861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1.
    van de Loosdrecht AA; Kok K; de Vries B; van der Veen AY; van den Berg E; Esselink MT; Marynen P; Vellenga E; van Imhoff GW
    Leukemia; 2000 Oct; 14(10):1857-8. PubMed ID: 11021761
    [No Abstract]   [Full Text] [Related]  

  • 26. EVI1 activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22).
    De Weer A; Poppe B; Cauwelier B; Carlier A; Dierick J; Verhasselt B; Philippé J; Van Roy N; Speleman F
    BMC Cancer; 2008 Jul; 8():193. PubMed ID: 18613965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.
    Qiao Y; Ogawa S; Hangaishi A; Yuji K; Izutsu K; Kunisato A; Imai Y; Wang L; Hosoya N; Nannya Y; Sato Y; Maki K; Mitani K; Hirai H
    Leukemia; 2003 Jun; 17(6):1112-20. PubMed ID: 12764377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression.
    Ohyashiki JH; Ohyashiki K; Shimamoto T; Kawakubo K; Fujimura T; Nakazawa S; Toyama K
    Blood; 1995 Jun; 85(12):3713-8. PubMed ID: 7780155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22.
    De Weer A; Speleman F; Cauwelier B; Van Roy N; Yigit N; Verhasselt B; De Moerloose B; Benoit Y; Noens L; Selleslag D; Lippert E; Struski S; Bastard C; De Paepe A; Vandenberghe P; Hagemeijer A; Dastugue N; Poppe B;
    Haematologica; 2008 Dec; 93(12):1903-7. PubMed ID: 18815193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of ETV6/MDS1/Evi-1 chimeric transcripts in a patient with acute myelocytic leukemia and t(3;12)(q26;p13).
    Nishimura Y; Wada H; Mori A; Takatsuka H; Tamura A; Fujimori Y; Okamoto T; Takemoto Y; Kakishita E
    Int J Hematol; 2000 Jul; 72(1):108-9. PubMed ID: 10979219
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24).
    Lennon PA; Abruzzo LV; Medeiros LJ; Cromwell C; Zhang X; Yin CC; Kornblau SM; Konopieva M; Lin P
    Cancer Genet Cytogenet; 2007 Aug; 177(1):37-42. PubMed ID: 17693189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia.
    Van Limbergen H; Beverloo HB; van Drunen E; Janssens A; Hählen K; Poppe B; Van Roy N; Marynen P; De Paepe A; Slater R; Speleman F
    Genes Chromosomes Cancer; 2001 Mar; 30(3):274-82. PubMed ID: 11170285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.
    Peeters P; Raynaud SD; Cools J; Wlodarska I; Grosgeorge J; Philip P; Monpoux F; Van Rompaey L; Baens M; Van den Berghe H; Marynen P
    Blood; 1997 Oct; 90(7):2535-40. PubMed ID: 9326218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations.
    Nucifora G; Begy CR; Kobayashi H; Roulston D; Claxton D; Pedersen-Bjergaard J; Parganas E; Ihle JN; Rowley JD
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4004-8. PubMed ID: 8171026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
    Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
    Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation.
    Yagasaki F; Wakao D; Yokoyama Y; Uchida Y; Murohashi I; Kayano H; Taniwaki M; Matsuda A; Bessho M
    Cancer Res; 2001 Dec; 61(23):8371-4. PubMed ID: 11731410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a t(10;12)(q24;p13) in a case of CML in transformation.
    Aguiar RC; Chase A; Oscier DG; Carapeti M; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 1997 Dec; 20(4):408-11. PubMed ID: 9408758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
    Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
    Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.